Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.41 USD | -5.97% | -11.80% | -6.17% |
Jun. 11 | MaxCyte CEO Maher Masoud buys 100,000 shares | AN |
Jun. 11 | Maxcyte Insider Bought Shares Worth $489,066, According to a Recent SEC Filing | MT |
Evolution of the average Target Price on MaxCyte, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering MaxCyte, Inc.
BTIG | |
Craig-Hallum | |
Stifel Nicolaus |
EPS Revisions
- Stock Market
- Equities
- MXCT Stock
- MXCT Stock
- Consensus MaxCyte, Inc.